Clinical Microbiology Market Size & Growth
According
to recent research findings presented by GME, the global
clinical microbiology market will gradually build up its revenue
at a CAGR of 6.5% from 2020 to 2026, in order to arrive at USD 5.4 billion by
2026. The demand for clinical microbiology testing is projected due to the
increasing health awareness coupled with the increase in number of contagious
diseases with disorders
Browse 148 Market Data Tables and 123
Figures spread through 179 Pages and in-depth TOC on "Clinical
Microbiology Market - Forecast to 2026"
https://www.globalmarketestimates.com/market-report/global-clinical-microbiology-market-2400
By
Disease (Respiratory Diseases, Bloodstream Diseases, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Periodontal Diseases, Urinary Tract Infections,
Other Indications), By Product Type (Instruments), By Application
(Pharmaceuticals Applications, Food Testing Applications, Clinical Applications,
Energy Applications, Chemical & Material Manufacturing,Environmental
Applications), By End-User (Hospitals & Diagnostics Centers, Custom Lab
Service Providers, Academic & Research Institutes, Others), By Region (North America,
Europe, Asia Pacific and Rest of the World); and Company Market Share Analysis
& Competitor Analysis
Key
Market Insights
·
The analysis of any microbe that causes human
infection is described as clinical microbiology.
·
Clinical Microbiology is specifically concerned with
infectious disease control, diagnosis, and treatment.
·
The pharmaceutical applicationwill be the quickest
developing section to hold the greatest piece of the overall industry as far as
income in the worldwide market as per the application outlook from 2020 to 2026
·
From 2020 to 2026, the respiratory diseasesapplicationis
analyzed to be the fastest growing market segment
Major
players in the clinical microbiology market include BioMérieux, Abbott
Laboratories, Hardy Diagnostics, Bruker Corporation, New Horizons, Bio-Rad
Laboratories, OpGen, Becton, Dickinson and Company, Thermo Fisher Scientific,
Hologic, Agilent Technologies, 3M, Memmert, Roche Diagnostics, Liofilchem,
VacutestKima, VacutestKima, QIAGEN, Shimadzu Corporation, TCS Biosciences,
Biotechnology Solutions, Arrow Diagnostics, and NEOGEN Corporation,among
others.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-clinical-microbiology-market-2400
DiseaseOutlook (Revenue, USD Million, 2020-2026)
·
Respiratory Diseases
·
Bloodstream Diseases
·
Gastrointestinal Diseases
·
Sexually Transmitted Diseases
·
Periodontal Diseases
·
Urinary Tract Infections
·
Other Indications
End-User (Revenue, USD Million, 2020-2026)
·
Hospitals
& Diagnostics Centers
·
Custom Lab
Service Providers
·
Academic &
Research Institutes, Others
ApplicationOutlook (Revenue, USD Million, 2020-2026)
·
Pharmaceuticals Applications
·
Food Testing Applications
·
Clinical Applications
·
Energy Applications
·
Chemical & Material Manufacturing
·
Environmental Applications
ProductOutlook (Revenue, USD Million, 2020-2026)
·
Instruments
·
Laboratory Instruments
·
Reagents
·
Microbial Analyzer
Regional Outlook (Revenue, USD
Million, 2020-2026)
North
America
·
U.S.
·
Canada
·
Mexico
Europe
·
Germany
·
UK
·
France
·
Spain
·
Italy
·
Rest of Europe
Asia Pacific
·
China
·
India
·
Japan
·
South Korea
·
Australia
·
Rest of APAC
Central & South America
·
Brazil
·
Argentina
·
Chile
·
Rest of CSA
Middle East & Africa
- Saudi
Arabia
- South
Africa
- UAE
- Rest
of MEA
Contact:
Tracy Simon
Email
address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
Check
our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
Comments
Post a Comment